Optimizing a drug’s clinical outcome is key to disease management. Standard Pharmaceutical Research Institute has continuously developed and expanded its  capabilities. We focus on innovative drug delivery systems that synchronize optimal drug dose to the target site to fight disease. 

Our drug delivery platforms (including osmotic-controlled release oral system, micro-encapsulation, pulsatile controlled release delivery, and lyophilization, etc.) allow for the development of complex formulations to target unmet patient needs. Drug delivery technologies can be used alone or in combination to develop a variety of generics, better than generics, or new drugs to improve efficacy, enhance safety and improve quality of life.